Condition

Cytomegalovirus Infections clinical trials and research

• 18Clinical trials
• 12Countries

Newest Cytomegalovirus Infections clinical trials

All recruiting trials (18)

• CMV-specific T cells after CMV reactivation in adults after HSCT

  This study tests CMV-specific immune recovery in adults who have their first CMV reactivation after an allogeneic HSCT to see how CMV-specific T cells change over time.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT07688759

• Biomarkers linked to congenital CMV using newborn blood spots

  Researchers will test protein and RNA markers in dried blood spots from newborns to see if they can identify congenital CMV sequelae early.

  Recruiting at 2 sites Copenhagen University Hospital, Rigshospitalet · Copenhagen and 1 other locations · NCT07635368

• T-cell–guided letermovir stopping after allogeneic stem cell transplant

  This tests whether using a CMV-specific T-cell blood test to decide when adult CMV-positive patients can stop letermovir after allogeneic stem cell transplant keeps them protected while avoiding unnecessary drug exposure.

  Recruiting Phase 4 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Beijing, Beijing Municipality and 11 other locations · NCT07569653

• Family-donor viral CTLs plus standard care vs standard care alone for refractory ADV or CMV infection after stem cell transplant

  This study tests whether using family-donor virus-specific CTLs in addition to usual treatment helps children, teens, and young adults with hard-to-treat CMV or adenovirus infections after a stem cell transplant.

  Recruiting Phase 3 New York Medical College · Valhalla, New York and 1 other locations · NCT07225972

• CMV-specific immunoglobulin to prevent CMV problems in children getting allogeneic stem cell transplants

  Doctors will try giving CMV-specific immunoglobulin to children having allogeneic stem cell transplants to prevent CMV reactivation and related transplant complications.

  Recruiting University of Pisa · Trieste · NCT07013370

• R-MVST cell therapy for viral infections in children and young adults

  This will try giving rapidly generated virus-specific T cells (R-MVST) to children and young adults whose weakened immune systems have recurrent or treatment-resistant infections with EBV, CMV, adenovirus, or BK virus.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06926894

• Partially HLA-matched virus-specific T-cell therapy for adenovirus, CMV, or EBV in immunocompromised patients

  This will try partially matched virus-specific T cells to treat adenovirus, CMV, or EBV infections in people whose immune systems are weakened after stem-cell or organ transplants or other immunodeficiencies.

  Recruiting at 2 sites Phase 1/2 Stanford University · Palo Alto, California and 2 other locations · NCT06909110

• Preventing CMV Infections in High-Risk Adults After Stem Cell Transplant

  This study is testing if giving a medication called letermovir for longer than usual can help prevent serious CMV infections in high-risk adults after they receive a stem cell transplant.

  Recruiting The First Affiliated Hospital of Soochow University · Suzhou, Jiangsu · NCT06812598

• Evaluating a software tool for diagnosing CMV infection in pregnant women

  This study is testing a new software tool to help doctors quickly and accurately diagnose CMV infections in pregnant women to ensure timely treatment for the health of the baby.

  Recruiting at 3 sites Assistance Publique - Hôpitaux de Paris · Limoges and 2 other locations · NCT06694428

• Individualized ATG dosing for stem cell transplantation

  This study is testing a personalized approach to dosing a medication for adults receiving stem cell transplants to see if it can reduce complications like infections and improve recovery.

  Recruiting Phase 2 Chinese PLA General Hospital · Beijing · NCT06572462

• Using letermovir to prevent CMV infection in kidney and pancreas transplant patients

  This study is testing if letermovir can help prevent CMV infections in adult kidney and pancreas transplant patients who are at high risk, while reducing their need for another medication called ganciclovir.

  Recruiting Phase 3 University of Wisconsin, Madison · Madison, Wisconsin · NCT06407232

• Ganciclovir-Resistant Cytomegalovirus in Organ and Stem Cell Transplants

  This study tests how often and why ganciclovir-resistant CMV occurs in adults after solid organ or hematopoietic stem cell transplants.

  Recruiting at 7 sites IRCCS Azienda Ospedaliero-Universitaria di Bologna · Houston, Texas and 22 other locations · NCT05234723

• Treatment of viral infections using rapidly generated T cells

  This study is testing a new treatment using specially made T cells to help patients with weakened immune systems who are struggling with serious viral infections like Epstein-Barr or cytomegalovirus.

  Recruiting Phase 1 Columbia University · New York, New York · NCT05183490

• Monitoring CMV infections in lung transplant patients

  This study looks at how well antiviral medication works to prevent CMV infections in lung transplant patients who might be at risk, while also checking for any side effects from the treatment.

  Recruiting University of Alberta · Edmonton, Alberta · NCT04439916

• Testing a blood assay to predict Cytomegalovirus reactivation in Ulcerative Colitis patients

  This study is testing a blood test to see if it can help predict when people with Ulcerative Colitis might have a Cytomegalovirus reactivation, so they can avoid unnecessary biopsies.

  Recruiting at 2 sites Centre Hospitalier Universitaire de Saint Etienne · Lyon and 1 other locations · NCT04030676

• Using virus-specific T-cells to treat CMV infections in young patients

  This study is testing a new treatment using special immune cells to help children and young adults with stubborn CMV infections after organ transplants when regular medicines haven’t worked.

  Recruiting at 9 sites Phase 2 New York Medical College · Los Angeles, California and 8 other locations · NCT03266640

• T Cell Therapy for Cytomegalovirus Infections

  This study is testing whether using special immune cells from donors can help patients who had a stem cell transplant fight off cytomegalovirus infections.

  Recruiting Early Phase 1 Case Comprehensive Cancer Center · Cleveland, Ohio · NCT02982902

• Infusing donor-derived virus-specific T-cells to treat post-transplant viral infections

  This study is testing if infusing special immune cells from donors can help patients who have had a stem cell transplant and are struggling with tough viral infections.

  Recruiting Phase 2 University Hospital, Basel, Switzerland · Basel · NCT02007356

Related topics

Quick answers

How many Cytomegalovirus Infections clinical trials are recruiting right now?

18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in United States (8 trials), China (4 trials), France (3 trials), Italy (2 trials), Switzerland (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 2, Phase 3: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →